Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants

Haiyan Xu, Qian Zhang, Li Liang, J. Li, Z. Liu, Guangjian Yang, Liya Yang, Jian Ying, S. Zhang, Y. WangAnnals 2019 · DOI

BibTeX
@article{xu2019crizotinib,
  author = {Haiyan Xu and Qian Zhang and Li Liang and J. Li and Z. Liu and Guangjian Yang and Liya Yang and Jian Ying and S. Zhang and Y. Wang},
  title = {{Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants}},
  journal = {Annals},
  year = {2019},
  doi = {10.1093/annonc/mdz260.075},
}

Loading related content...

Figure